Highlights Jianmin Pharmaceutical Group Co.,Ltd.

Equities

600976

CNE000001HB7

End-of-day quote Shanghai S.E. Other stock markets 23:00:00 03/06/2024 BST			5-day change	1st Jan Change
66 ^CNY	+2.28%		+1.32%	+1.15%

04-19	Jianmin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-16	Jianmin Pharma Gets Nod to Market Asthma Drug	MT

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Jianmin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-19	CI
Jianmin Pharma Gets Nod to Market Asthma Drug	04-16	MT
Jianmin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	03-15	CI
Jianmin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	20/10/23	CI
Jianmin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	08/08/23	CI
Jianmin Pharmaceutical Group Co.,Ltd. completed the acquisition of 6.13% stake in HeraMED Limited from Hua Li Pharmaceutical Group Co.,Ltd.	24/07/23	CI
Jianmin Pharma Gets Nod to Market Atomoxetine Hydrochloride Oral Solution; Shares Drop 3%	25/05/23	MT
Jianmin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	17/04/23	CI
Jianmin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	14/03/23	CI
Jianmin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	14/03/23	CI
Jianmin Pharma to Buy 4.5% of Australia’s Hera Med for 8.4 Million Yuan	28/12/22	MT
Jianmin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	21/10/22	CI
Jianmin Pharmaceutical Group Co.,Ltd. intends to acquire Zhejiang Huafang Medical Care Co., Ltd from Holley Group Company Limited, Zhejiang Holley Investment Management Co., Ltd. and Suzhou Yuanyi Zhiyuan Equity Investment Partnership (Limited Partnership) for CNY 15.2 million.	16/08/22	CI
Jianmin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	19/07/22	CI
Jianmin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	15/04/22	CI
Jianmin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	17/03/22	CI
Jianmin Pharmaceutical Group Co.,Ltd. intends to acquire 6.13% stake in HeraMED Limited from Hua Li Pharmaceutical Group Co.,Ltd. for AUD 2.1 million.	12/11/21	CI
Jianmin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21/10/21	CI
Jianmin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	19/07/21	CI
Jianmin Pharmaceutical Group Co., Ltd.'s Equity Buyback announced on July 7, 2020, has expired.	04/07/21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Jianmin Pharmaceutical Group Co.,Ltd.

Equities

600976

CNE000001HB7

Highlights

Filters